Gemcitabine plus CI-994 offers no advantage over gemcitabine alone in the treatment of patients with advanced pancreatic cancer: results of a phase II randomized, double-blind, placebo-controlled, multicenter study.
暂无分享,去创建一个
A. Rosemurgy | D. Wagener | S. Krishnamurthi | D. Waterhouse | S. Gulyas | D. Richards | W. Grove | K. Boehm | K. Macdonald | D. Wagener | M. Clark | K. Dasse | Alexander S. Rosemurgy